Thromboembolic Complications After Cardioversion of Acute Atrial Fibrillation

The FinCV (Finnish CardioVersion) Study September 1, 2013 Objectives  This study sought to explore the incidence and risk factors of thromboembolic complications after cardioversion of acute atrial fibrillation. Background  Anticoagulation therapy is currently recommended after cardioversion of acute atrial fibrillation in patients with risk factors for stroke, but the implementation of these new consensus-based guidelines has been […]

Prevention of Thromboembolism After Cardioversion of Recent-Onset Atrial Fibrillation

September 1, 2013 Brief Is Not Always Safe∗ Atrial fibrillation (AF) is the most common human arrhythmia causing a significant public health burden. Restoration of sinus rhythm by cardioversion of the arrhythmia, performed either electrically or pharmacologically, has been a main therapeutic option for the treatment of AF patients during the last decades. After publication […]

Epicardial Adipose Tissue Thickness and Ablation Outcome of Atrial Fibrillation

Plosone:   9/16/13 Epicardial fat was closely related to atrial fibrillation (AF). Transthoracic echocardiography (TTE) has been proposed to be a convenient imaging tool in assessing epicardial adipose tissue (EAT). The goal of the present study was to investigate whether the EAT thickness measured on TTE was a useful parameter in predicting procedural outcomes of AF […]

Atherosclerosis/Lipoproteins: Carotid Atherosclerosis and Incident Atrial Fibrillation

ATVBAHA: September 12, 2013 Objective—Atrial fibrillation (AF) and atherosclerotic vascular disease are closely entangled disorders and often coexist. Whether atherosclerosis predisposes to the development of AF has not been fully elucidated. Approach and Results—This study was performed within the framework of the Bruneck Study, a population-based survey with near-complete participation (932 of 1000), long-term follow-up […]

New StopAfib.org Video Explains the Hidden Afib Risks for Atrial Fibrillation Awareness Month

September 12, 2013 September Is Atrial Fibrillation Awareness Month: StopAfib.org Video Explains the Hidden Afib Risks Dallas, TX, September 11, 2013 — Atrial fibrillation (also called afib or AF) is an irregular heartbeat (or heart rhythm) and is a much more serious condition than many patients – and their family members – realize. Many patients […]

Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial

PLOSONE: 9/9/13 Stroke prevention in atrial fibrillation (AF), most commonly with warfarin, requires maintenance of a narrow therapeutic target (INR 2.0 to 3.0) and is often poorly controlled in practice. Poor patient-understanding surrounding AF and its treatment may contribute to the patient’s willingness to adhere to recommendations. Method A theory-driven intervention, developed using patient interviews and […]

Stroke Propensity Is Increased under Atrial Fibrillation Hemodynamics: A Simulation Study

PLOS: 9/5/13 Atrial fibrillation (AF) is the most common sustained dysfunction in heart rhythm clinically and has been identified as an independent risk factor for stroke through formation and embolization of thrombi. AF is associated with reduced cardiac output and short and irregular cardiac cycle length. Although the effect of AF on cardiac hemodynamic parameters […]

Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention

JACC: September 10, 2013 Objectives  The purpose of this study was to investigate the risk of thrombosis and bleeding according to multiple antithrombotic treatment regimens in atrial fibrillation (AF) patients after myocardial infarction (MI) or percutaneous coronary intervention (PCI). Background  The optimal antithrombotic treatment strategy is unresolved in patients with multiple indications. Methods  A total of 12,165 AF […]

Atrial Fibrillation Awareness Month 2013

atrialfibrillationblog: 9/5/13 What you don’t know about atrial fibrillation could kill you, or a loved one! Atrial fibrillation (also called afib) is an irregular heartbeat (or heart rhythm), and is a major cause of strokes. Having afib increases your stroke risk by 500 percent. In addition, afib can lead to heart failure, dementia, and even Alzheimer’s […]

Arrhythmia and Electrophysiology

J Am Heart Assoc.: September 3, 2013 Background Atrial fibrillation (AF) patterns and their relations with long‐term prognosis are uncertain, partly because pattern definitions are challenging to implement in longitudinal data sets. We developed a novel AF classification algorithm and examined AF patterns and outcomes in the community. Methods and Results We characterized AF patterns between 1980 and […]

National Minority Quality Forum
Clinical Trial Engagement Network Map Childhood Obesity MapHIV Z-Atlas: Peripheral Arterial Disease Atlas Map Lung Cancer Index Z-Atlas: Chronic Kidney Disease AFIB Index Cardiometabolic Health Aliance Minority Diabetes Coalition U.S. Diabetes Index County Edition U.S. Diabetes Index Research Edition Medicare Index Medicare Index Stroke Edition About The Minority Stroke Working Group Hepatitis C Disease Index Lead Risk Index Map MRSA StrokePAD Minority Index The South Texas Diabetes Initiative Minority Stroke Consortium YouTube NMQF Videos IPAB Action Center National Health Index

© 2011 National Minority Quality Forum, Inc. All Rights Reserved.